High component cost may push up mobile prices by 18%
The industry may again see double-digit growth in FY23, given that the impact of the Omicron variant is limited
For the October-December period, TSMC's net profit reached a record NT$166.23 billion
For now, the direct hit from Omicron on output appeared subdued, according to surveys released on Monday and Tuesday.
Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world
The government continues to make efforts to move up in the global electronics supply chain and is expected to come up with new policies and incentive schemes for wearables and IT hardware
During the first wave of the pandemic in 2020, a contraction in the services sector was sharper than in manufacturing and took seven months to return to expansion territory.
The chief minister proposed the drone manufacturing unit, given the importance of unmanned aircraft in various fields such as disaster relief, agriculture, and law and order, a spokesperson said
The Yogi Adityanath government has promised to offer a slew of incentives and support to the companies and technology startups for setting up semiconductor units in the state
Expect to see more local manufacturing announcements in 2022
World's third-largest economy is set to post a solid rebound this quarter after a larger-than-expected contraction in July-September.
Apple was forced to stop its assembly line for several days first time in more than 10 years due to supply chain limitations and China's ongoing power restriction in October.
Business Standard brings you the top stories on Wednesday
Towards the end of the month, the newly-detected Omicron coronavirus variant emerged as a fresh worry for policymakers
Shakti Pumps India manufactures and supplies solar pumps and motorised pumps
Firm expanding mRNA lipids capacity 10-fold, overall plant capacity by 6 times by June
KIL on Tuesday posted an over two-fold jump in its consolidated net profit
Fresh rules on product standards and a steep rise in basic customs duty have altered the dynamics of the industry but not necessarily to the benefit of small players
Union Chemicals and Fertilisers Minister Mansukh Mandaviya on Wednesday urged the pharma industry to make India a manufacturing base as the country is a safe destination for investments. Addressing the Investor Summit on 'Opportunities & Partnerships in Pharma & Medical Devices', the minister spoke about the government's pro-industry reforms and efforts to make India the best investment destination in the world. "I would like to tell investors what PM Modi has already said. Please come and manufacture in India, set up industry here. The country provides a safe investment environment as you would find in your own countries," Mandaviya said in an online event. He noted that the government has been taking constant steps to enhance investments in the country and the global pharma industry should take benefit from it. There were no biases against people coming to invest from outside and everyone was treated equally, Mandaviya said, outlining the reasons for growth of the industry ..
In this exclusive interview, Dixon Technologies CMD Sunil Vachani talks about what his company wants to achieve through the PLI scheme, its planned investments and acquisitions, besides much else